Healthcare Asia Summit - April 9, 2025

Dr. Shuba Srinivasan is the Chief Executive Officer of Prince Court Medical Centre, leading its strategic expansion, operational transformation, and clinical innovation. A seasoned healthcare executive with over 28 years of experience, she has been at the forefront of shaping hospital governance, quality standards, and business growth.
 
Previously serving as Vice President of Medical Affairs & Quality at IHH Healthcare Malaysia, Dr. Shuba played a key role in strengthening clinical governance and steering resilience strategies during the Covid-19 pandemic. Now, as CEO of Prince Court, she is driving international partnerships, digital health initiatives, and premier patient services, ensuring the hospital remains a leading force in global healthcare.
 
Her leadership philosophy is centred on excellence, strategic growth, and elevating patient outcomes, reinforcing Prince Court’s standing as a destination of choice for world-class medical care.

Dr. Seow is a specialist in Emergency Medicine and Critical Care Medicine. He earned his Medical Doctor degree in Taiwan and later completed a Master of Science in Clinical Service Operations at Harvard Medical School. With 20 years of experience in both management and clinical practice across various hospitals, both locally and abroad, Dr. Seow brings a wealth of knowledge to his role. He currently oversees operations at Sunway Medical Centre in Sunway City, the largest private quaternary hospital in Malaysia.

Navjeewan (Nav) Khosla joined Novo Holdings Asia in August 2021. As a Partner, he focuses on dealsourcing and execution as well as managing and developing the growing portfolio of investments, primarily in China, India, and Southeast Asia.

Prior to joining Novo Holdings Asia, Nav was a Director in Quadria Capital, a mid-market private equity firm focusing on healthcare investments in India and Southeast Asia. Before joining Quadria Capital, he was the Managing Director at Fosun, where he worked on both private and public healthcare investment opportunities across the Asia-Pacific region. Nav started his investment career with Merrill Lynch in Hong Kong and moved to UBS Global Asset Management in Singapore before joining Fosun.

Nav holds an MBA from Indian Institute of Management (IIM), Ahmedabad, in India and Bachelor of Technology from Indian institute of Technology (IIT), Kharagpur in India.

Ling Lee has 18 years of experience in the healthcare industry, specialising in strategy development, hospital acquisition, operational leadership, lean management and financial management.

Prior to joining Gleneagles Hospital Kuala Lumpur, Ling Lee was the Chief Executive Officer at Pantai Hospital Ampang and the Head of Strategy and Special Projects for IHH Healthcare Malaysia for 10 years, overseeing the organisation’s overall strategy and business development and instrumental in many greenfield and brownfield projects in the country.

Ling Lee was with Singapore General Hospital (SGH) and National University Hospital (NUH) Singapore before returning home to Malaysia. She loves sharing her healthcare experiences and she is a Visiting Lecturer at International Medical University (IMU). She takes on topic relating to healthcare strategy and healthcare operations.

Ling Lee has a Degree of Economics from National University of Malaysia (UKM) and is currently pursuing her Masters of Law from Taylor’s Law School.

Chris is a Partner at Pureland Venture, looking after value creation activities for post-investment scale-up of healthtech innovation companies.

In addition, Chris moreover serves in the KPMG Global Health Centre of Excellence and as a strategic advisor for policy dialogue at APACMed (with a particular focus in the digital health domain).

Chris holds additional healthcare ecosystem roles too ranging from public/private UHC design taskforces through to visiting lectureship at leading academic centres.

Chris is presently based in Singapore, having lived and worked around the globe; he is most passionate about bringing safe, effective, economically-viable medical innovations to those populations in need.

Ren Jun Lim is a Principal of Baker McKenzie Wong & Leow’s Intellectual Property & Technology (IPTech) practice group, and also co-leads the Firm’s Healthcare industry group. He represents local and international clients in both contentious and non-contentious intellectual property and technology matters.

Ren Jun keenly advises on a full range of issues relating to the healthcare industry. These include regulatory compliance in respect of digital healthcare, telemedicine, drugs, medical devices, health supplements, food products, and cosmetics; clinical trials; product liability/recall issues; data exclusivity; patent linkage; competition; and anti-corruption issues.

Eric Woo is the Vice President of ECRI Asia Pacific and is responsible for the business development activities, research initiatives, project execution, and operational management in the APAC region. With 26 years of experience in healthcare, including managing a private hospital and working with medical technology organizations, Eric brings a wealth of expertise to advancing healthcare innovation and patient safety. 

Before joining ECRI in 2015, Eric served as Chief Operating Officer of a private hospital specializing in sports injuries and stem cell technology. His career highlights include improving hospital operational workflows, introducing new technologies to the Asian healthcare market, and driving evidence-based approaches to technology adoption. 

Eric is a strong advocate for managing patient safety risks through a systems approach that integrates people, processes, and technology. He frequently consults and presents on Healthcare Technology Management (HTM), policy implementation, and patient safety to healthcare authorities, regulators, and organizations across Asia Pacific.